Vertex and CRISPR Therapeutics Complete Submission of Rollin

-EU and UK filings completed in 2022; submissions validated by EMA and MHRA and the review procedure has begun as of January 2023-

... | April 3, 2023

Related Keywords

Boston , Massachusetts , United States , Cambridge , Cambridgeshire , United Kingdom , Australia , San Francisco , California , Switzerland , London , City Of , America , American , Phuong Khanh , Carmen Bozic , Therapeutics Inc , American Society Of Hematology , Facebook , Drug Administration , Youtube , Vertex Pharmaceuticals Incorporated Nasdaq , Global Medicines Development , Twitter , Regulatory Agency , Linkedin , Exchange Commission , European Commission , European Medicines Agency , Vertex Pharmaceuticals , Viacyte Inc , Instagram , Vertex Pharmaceuticals Incorporated , Biologics License Applications , Priority Review , American Society , Annual Meeting , Executive Vice President , Medical Affairs , Chief Medical Officer , Regenerative Medicine Advanced Therapy , Fast Track , Orphan Drug , Rare Pediatric Disease , Marketing Authorization Applications , Orphan Drug Designation , Priority Medicines , Innovation Passport , Innovative Licensing , Access Pathway , New England Journal , Gene Editing Process , Innovation District , North America , Top Employers , Best Workplaces , Private Securities Litigation Reform Act , While Vertex , Vertex Pharmaceuticals Stock Exchange , News , Information , Press Release , End , Uk , Filings , Ompleted , N , Submissions , Validated , Y , Ma , Phra , The , Review , Procedure , Gas , Egun , Us , F , Anuary Vrtx Us92532f1003 ,